OxSyBio

About:

OxSyBio is developing 3D printing techniques to produce a range of tissue-like & functional tissues for medical research.

Website: http://www.oxsybio.com

Twitter/X: oxsybio

Top Investors: Parkwalk Advisors, IP Group, Oxford University Innovation, Woodford Investment Management

Description:

OxSyBio's vision is to ultimately produce tissues that can be used by patients in the clinic for precision medicine and organ repair or replacement. At OxSyBio, they are developing 3D printing techniques to produce a range of tissue-like and functional tissues for medical research and clinical applications. Their technology is based on cutting-edge research conducted by Professor Hagan Bayley’s group in the Chemistry Department at the University of Oxford. A leader in the exploration of chemical and synthetic biology his expertise cover membrane protein structure and function, single molecule chemistry and 3D printing.